SYNTHETIC CANNABINOIDS TRYPTAMINES There was 1 iden�fica�on each of 4-OH-MET, 4-AcO- DMT, and 5-MeO-MiPT this repor�ng period. 4-OH-MET was iden�fied for the first �me during the first half of CY 2017. CATHINONES OPIOIDS/ ANALGESICS EMERGING THREAT REPORT 2017 Drug Enforcement Administra�on Special Testing and Research Laboratory U S D e p a rt m e n t o f . . J u s tic e D ru g E nfo rc e m e nt A dm in ist r a t i o n . HALLUCINOGENS Mid-Year FOR OFFICIAL USE ONLY The Special Tes�ng and Research Laboratory’s Emerging Trends Program compiled the data for this report through a query of archived seizure and analysis informa�on from drug evidence analyzed by the Drug Enforcement Administra�on’s laboratory system. This data is representa�ve of drug evidence seized and analyzed in the date ranges annotated. This is not a comprehensive list of all new psychoac�ve substances and is not representa�ve of all evidence analyzed by DEA. This data is a mid-year snapshot of the new psychoac�ve substance market in the United States. The term new psychoac�ve substance (NPS) describes a recently emerged drug that may pose a public health threat. This includes synthe�c cannabinoids, subs�tuted cathinones, phenethylamines, opioids, tryptamines, benzodiazepines, and a variety of other chemical classes. Due to the recent increase in seizures, fentanyl is also included in this report. An iden�fica�on is made when authen�cated reference material is available for comparison. When reference material is not available, the drug evidence is iden�fied as “substance unconfirmed”. A single unit of drug evidence may have mul�ple sub-units. For the purposes of this document, each unit of drug evidence counts as one iden�fica�on regardless of the number of sub-units. Some seized drug evidence contains more than one ac�ve ingredient; therefore, more than one iden�fica�on can be made for a single unit. Questions about this data are welcome and may be directed to the DEA Emerging Trends Program at 703-668-3300 or DEA.Emerging. [email protected]. There were 2 iden�fica�ons each of 25C-NBOMe and 25I-NBOMe this repor�ng period. 260 96 33 32 13 9 8 6 6 4 3 2 2 1 1 1 FUB-AMB 5F-MDMB-PINACA ADB-FUBINACA MMB-CHMICA AB-FUBINACA ADB-CHMINACA MDMB-FUBINACA 5F-AMB AB-CHMINACA 5F-UR-144 AB-PINACA FUB-AKB48 SDB-005 5F-AB-PINACA FUB-144 NM2201 546 137 68 22 18 14 13 10 5 3 2 2 Fentanyl Furanyl fentanyl U-47700 Acryl fentanyl Carfentanil 4-ANPP Acetylfentanyl 4-FiBF Methoxyacetylfentanyl Butyryl fentanyl 3-Methylfentanyl Tetrahydrofuran fentanyl Fentanyl accounted for 65% of the opioid iden�fica�ons. Of the 546 fentanyl iden�fica�ons, fentanyl was found as the only controlled substance in approximately 45% of the iden�fica�ons and was found in combina�on with heroin in approximately 49% of the iden�fica�ons. Furanyl fentanyl was the next most prominent opioid accoun�ng for approximately 16% of the iden�fica�ons. 61 25 12 6 N-Ethylpentylone Dibutylone THERE WERE 121 CATHINONE IDENTIFICATIONS THIS REPORTING PERIOD. N-ETHYLPENTYLONE ACCOUNTED FOR APPROXIMATELY 50% OF THE IDENTIFICATIONS. DIBUTYLONE WAS THE NEXT MOST PROMINENT CATHINONE ACCOUNTING FOR APPROXIMATELY 21% OF THE IDENTIFICATIONS. THERE WERE 477 SYNTHETIC CANNABINOID IDENTIFICATIONS THIS REPORTING PERIOD. FUB-AMB ACCOUNTED FOR APPROX. 55% OF THE IDENTIFICATIONS. OTHER There were 19 instances of unconfirmed substances during this repor�ng period. Addi�onally, there were 18 iden�fica�ons of e�zolam, 4 iden�fica�ons of DMAA and TFMPP, 2 iden�fica�ons of 5-EAPB and methoxetamine, and 1 iden�fica�on each of 3- fluorophenmetrazine, 4-MeOPP, 5-MAPB, 6-APB, deschloroketamine, and mitragynine. 4 3 3 3 1 1 1 1 4-CEC α-PVP TH-PVP 4-MeAPP Ethylone Pentylone 3,4-Methylenedioxy-α-PBP 4-Cl-α-PVP 4-F-α-PVP 4-MMC No new synthetic cannabinoids were identified in the first half of CY 2017. FUB-AMB has remained the most identified synthetic cannabinoid since the 4th quarter of CY 2016. MMC = Methylmethcathinone PBP = Pyrrolidinobutiophenone MeAPP = Methylethylaminopentiophenone PVP = Pyrrolidinovalerophenone CEC = Chloroethcathinone Tetrahydrofuran fentanyl and methoxyacetylfentanyl were identified for the first time during the first half of CY 2017.